Lion's Mane and Anxiety Reduction: Mechanisms and Studies

Mushrooms for Anxiety and Stress

4 weeks of lion's mane intake significantly reduced anxiety in a double-blind placebo-controlled trial

Nagano and colleagues (2010) randomized 30 women to lion's mane cookies or placebo for 4 weeks and found significant reductions in anxiety and irritability. The mechanism behind this result is hippocampal neurogenesis driven by NGF and BDNF upregulation.

Nagano et al., Biomedical Research, 2010

Pan-neurotrophic

Martinez-Marmol et al. (2023) showed hericerin activates NGF, BDNF, and NT-3 signaling simultaneously: three growth factors with distinct anxiolytic and antidepressant mechanisms from a single compound

Neurogenesis-dependent

Chong et al. (2021) used neurogenesis ablation to prove that hippocampal neurogenesis is required for lion's mane's antidepressant effect; it disappears when neurogenesis is blocked

Same-day effects

Surendran et al. (2025) documented acute mood improvement in healthy young adults within hours of a single dose, suggesting faster mechanisms alongside the weeks-long neurogenesis pathway

Nagano et al., Biomedical Research, 2010

View as image ↗

The research on lion's mane and anxiety is more specific than most people realize. It is not just about NGF making neurons "healthier" in a general way. The mechanism is identified: hippocampal neurogenesis, confirmed as required for the anxiolytic effect through a controlled ablation experiment. The clinical evidence is real: a double-blind trial in humans showing significant anxiety reduction within four weeks. And the 2023 discovery that a single hericerin compound activates three different neurotrophic pathways simultaneously is the kind of finding that never makes it to supplement marketing.

This article covers what the evidence actually shows and what it does not, including the honest answer to whether lion's mane can sometimes worsen anxiety in certain people. For context on the full range of mushrooms used for stress and anxiety, see adaptogenic mushrooms for stress: how they help your body cope.

The Nagano 2010 Trial: The Foundational Clinical Evidence

The most-cited human study on lion's mane and anxiety comes from Nagano and colleagues, published in Biomedical Research in 2010.^[1]

The trial enrolled 30 menopausal women and randomized them to lion's mane cookies (containing Hericium erinaceus powder) or placebo cookies for four weeks. The primary outcomes included anxiety, irritability, concentration, and other mood-related measures assessed by questionnaire.

The lion's mane group showed significant reductions in anxiety and irritability compared to placebo at the end of the four-week period. The population choice (menopausal women) is notable because hormonal changes during menopause are associated with increased anxiety, making this a population with elevated anxiety burden. The effect was detectable in four weeks, which is faster than most pharmacological treatments for anxiety require to show measurable benefit.

Limitations worth naming: 30 participants is a small trial. Cookies are not a standardized extract formulation with defined compound content. Women-only population limits generalizability. These are real limitations. But the directional signal is consistent with the preclinical mechanism, and it remains the primary human-specific anxiety data for lion's mane.

How Does Lion's Mane Reduce Anxiety? The Neurogenesis Mechanism

The answer to "how does lion's mane reduce anxiety" can be given in roughly 40 words: erinacines and hericenones from lion's mane stimulate nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) synthesis, which promote hippocampal neurogenesis (growth of new neurons in the memory and emotion center of the brain), producing anxiolytic and antidepressant effects.

The hippocampus is where this matters most. Anxiety and depression are both associated with reduced hippocampal neurogenesis. Chronic stress suppresses the growth of new neurons in the hippocampus; most antidepressant drugs work, at least in part, by restoring hippocampal neurogenesis. This is not just correlation; it is a documented mechanism.

Ryu and colleagues (2018) demonstrated this with lion's mane specifically: their mouse study showed that H. erinaceus extract promoted hippocampal neurogenesis and simultaneously reduced anxiety and depressive behaviors.^[6] The key question at that point was whether the neurogenesis and the anxiolytic effect were merely parallel outcomes of the same treatment, or whether the neurogenesis was actually causing the anxiolytic effect.

Proving the Mechanism: The Chong 2021 Ablation Study

Chong and colleagues answered that causal question in 2021 with a neurogenesis ablation study.^[7]

Neurogenesis ablation means using a chemical agent (in this case, temozolomide) to kill neural progenitor cells, specifically blocking the ability of the hippocampus to produce new neurons. Then testing whether the treatment of interest still produces its behavioral effects.

If lion's mane's anxiolytic effects are independent of neurogenesis, they would persist even when neurogenesis is blocked. If neurogenesis is required, blocking it should eliminate the effects.

The result: when hippocampal neurogenesis was ablated, lion's mane's antidepressant-like effects disappeared. The behavioral improvements that lion's mane produced in normal animals did not occur in animals where neurogenesis was blocked.

This established a causal relationship rather than just a correlation. Lion's mane's anxiolytic effects are neurogenesis-dependent. This is editorial gold because it moves beyond "associated with" into mechanistic causality, which most plant and mushroom compound research never achieves.

Chong and colleagues' 2019 review further synthesized the therapeutic potential of H. erinaceus for depressive disorder, placing the neurogenesis mechanism within the broader evidence context.^[4]

Pan-Neurotrophic: NGF, BDNF, and NT-3 Simultaneously

The Martinez-Marmol 2023 finding deserves its own section because it fundamentally changes the mechanistic picture.^[8]

Most discussions of lion's mane focus on NGF (nerve growth factor) as the primary anxiolytic/neuroprotective mechanism. Martinez-Marmol and colleagues showed that hericerin derivatives activate a pan-neurotrophic pathway: they stimulate not just NGF, but also BDNF (brain-derived neurotrophic factor) and NT-3 (neurotrophin-3) simultaneously, all converging on ERK1/2 signaling in hippocampal neurons.

This matters because each neurotrophic factor has somewhat distinct functions in anxiety and mood regulation:

• NGF: neuron survival and new connection formation
• BDNF: hippocampal neurogenesis (this is the primary target of most antidepressants), synaptic plasticity
• NT-3: proliferation and differentiation of neural progenitor cells in the hippocampus

Activating all three from a single compound through a common signaling node (ERK1/2) means lion's mane is producing neurotrophic support across a wider range of hippocampal plasticity processes than NGF stimulation alone would. No consumer article covers this finding. No supplement brand mentions NT-3. It is the kind of mechanistic detail that sits in JAMA-level journals and never reaches people actually taking the supplement.

The practical implication is that fruiting body extracts (which contain hericerins) may have complementary anxiolytic mechanisms to mycelium extracts (which contain erinacines). For more on how these compounds differ, see erinacines: the compounds that cross the blood-brain barrier.

The BDNF Biomarker: Human Evidence for the Mechanism

Vigna and colleagues (2019) added a critical piece: human biomarker data.^[2]

Their trial enrolled overweight and obese patients who reported mood and sleep difficulties. Lion's mane supplementation improved mood scores and sleep quality, and alongside these behavioral improvements, blood levels of BDNF rose in the treatment group. The increase in circulating BDNF correlated with the mood improvement.

BDNF is the biomarker most directly connected to hippocampal neurogenesis and anxiety regulation. It can be measured in blood. Its rise in Vigna's trial bridges the animal mechanism (lion's mane increases BDNF, which drives hippocampal neurogenesis and reduces anxiety) to a human measurement. The anxiety/mood improvement was not occurring despite unchanged BDNF; it was occurring alongside rising BDNF levels. The mechanism that preclinical studies established was reflected in a human biological measure.

Acute Effects: Same-Day Mood Improvement

The standard framing of lion's mane's anxiolytic mechanism is slow: neurogenesis takes weeks. Nagano's 2010 trial ran four weeks. Most guidance says "give it time."

Surendran and colleagues (2025) complicated this picture.^[10] Their double-blind, randomized, placebo-controlled study in healthy young adults found acute mood improvements occurring within hours of a single lion's mane dose. This is not consistent with a neurogenesis-dependent mechanism (new neurons do not grow within hours).

The acute effects likely involve faster-acting pathways. Li and colleagues (2018) reviewed the neurohealth properties of erinacine-enriched mycelium and identified multiple rapid signaling effects alongside the slower neurogenesis pathway.^[3] Batty and colleagues (2023) similarly documented both acute and chronic mood effects in a parallel-groups study in young adults.^[9]

The practical conclusion from these findings: lion's mane has two timescales for anxiety and mood effects. Acute effects, detectable within hours via faster signaling mechanisms, and chronic effects via neurogenesis, requiring weeks to develop. Evaluating lion's mane only over a short window misses the neurogenesis pathway; feeling no change in the first week does not mean it is not working.

Lion's Mane vs. Reishi for Anxiety: Different Mechanisms

The two mushrooms most researched for anxiety and mood operate through entirely different biological pathways. Understanding this changes how to think about choosing between them.

Lion's mane: neurogenesis pathway. The mechanism runs through NGF, BDNF, and NT-3 upregulation, hippocampal neurogenesis, and structural changes in how the brain processes stress and emotion. It is a growth-oriented mechanism: rebuilding the hippocampal capacity that chronic stress erodes.

Reishi: GABAergic and HPA axis modulation. Reishi (Ganoderma lucidum) compounds including triterpenes and polysaccharides modulate GABA receptor activity (the same receptor type that benzodiazepines target) and regulate cortisol output through the hypothalamic-pituitary-adrenal (HPA) axis. This is a calming/suppression mechanism rather than a growth mechanism.

These are complementary targets, not competing ones. Lion's mane addresses the structural deficit (reduced hippocampal neurogenesis under chronic stress). Reishi addresses the hyperactivation (elevated cortisol, reduced GABAergic inhibition). A person whose anxiety is primarily driven by high cortisol and hyperarousal may respond differently than a person whose anxiety is driven by hippocampal atrophy from chronic stress.

Lazur and colleagues (2023) reviewed the potential mechanisms of medicinal mushrooms' antidepressant activity across multiple species, placing lion's mane's neurogenesis mechanism alongside the different pathways of other fungi.^[12]

Can Lion's Mane Cause Anxiety? The Honest Answer

Some users report initial increases in anxiety when starting lion's mane. This is not confirmed in any randomized controlled trial and does not appear as a documented adverse effect in the Menon 2025 systematic review of H. erinaceus supplementation.^[11]

The most plausible explanation, and it is speculative, involves the acute NGF stimulation. NGF at high levels can have paradoxical stimulating effects in some neurological contexts. If someone is sensitive to the acute signaling effects of lion's mane's erinacines and hericerins, they might experience transient over-stimulation before the neurogenesis pathway produces its calming effects.

This is anecdotal. No study has confirmed it as a mechanism. If someone experiences worsened anxiety at the start of lion's mane use, the options are to reduce the dose and titrate up slowly, try a different formulation (fruiting body vs. mycelium), or discontinue. Rodriguez and colleagues' 2022 study in the rTg4510 tau mouse model documented anxiolytic effects, with no adverse anxiety-related outcomes in the treated animals.^[5]

What Doses and Timelines Do the Trials Show?

Across the human trials, effective doses range from relatively modest:

• Nagano 2010: approximately 5g daily of dried powder in cookies (low-concentration preparation)
• Vigna 2019: specific extract dose with standardized content
• Batty 2023 and Surendran 2025: standardized extracts in the 1-2g range

The dose variation reflects different formulations: dried powder has different compound concentrations than standardized extracts. Looking at the clinical evidence as a guide, most studies use products delivering meaningful erinacine and hericenone content at doses of 500mg to 3g daily of standardized extract.

Timeline: Nagano's four-week trial showed effects at four weeks. Ryu's 2018 preclinical work showed neurogenesis effects over weeks of treatment, not days. For the neurogenesis-dependent anxiolytic effect, a minimum of 4-8 weeks of consistent daily use is the honest timeline from the clinical evidence.

The Menon 2025 systematic review of lion's mane benefits and side effects found the compound well-tolerated across the range of doses studied, with no serious adverse events reported in the reviewed trials.^[11]

The Bottom Line

Lion's mane reduces anxiety through a neurogenesis-dependent mechanism: erinacines and hericenones stimulate NGF, BDNF, and NT-3 (Martinez-Marmol 2023), driving hippocampal neurogenesis confirmed as causally required by Chong 2021's ablation study. Nagano 2010's 4-week RCT in 30 women documented significant anxiety reduction; Vigna 2019 added rising BDNF as a human biomarker correlate. Surendran 2025 and Batty 2023 showed acute mood effects within hours, indicating faster mechanisms alongside the weeks-long neurogenesis pathway. No study confirms lion's mane causes anxiety, though anecdotal reports exist; the Menon 2025 systematic review found no serious adverse effects across the evidence base.

Frequently Asked Questions

Does lion's mane help with anxiety?

Yes, based on a double-blind placebo-controlled trial. Nagano et al. (2010) found that 4 weeks of lion's mane powder significantly reduced anxiety and irritability in 30 women compared to placebo. Preclinical studies have confirmed the mechanism: hippocampal neurogenesis driven by NGF and BDNF upregulation. The effect requires consistent use over weeks, not days, to develop through the neurogenesis pathway, though some users report acute mood improvement within hours of dosing.

How does lion's mane reduce anxiety?

Lion's mane reduces anxiety through hippocampal neurogenesis. Erinacines from the mycelium stimulate NGF synthesis; hericenones from the fruiting body activate NGF, BDNF, and NT-3 simultaneously via ERK1/2 signaling (Martinez-Marmol 2023). These growth factors drive new neuron growth in the hippocampus, the brain region most affected by chronic stress. Chong et al. (2021) confirmed this mechanism is causally required: blocking hippocampal neurogenesis eliminated lion's mane's antidepressant-like effects.

How long does it take for lion's mane to work for anxiety?

Based on the clinical evidence, 4-8 weeks of consistent daily use. The neurogenesis pathway (the confirmed mechanism for anxiety reduction) takes weeks to produce measurable new neuron growth. Nagano's 2010 trial showed significant anxiety reduction at 4 weeks. Some users report acute mood effects within hours of dosing (Surendran 2025 documented same-day effects), but these likely reflect faster signaling mechanisms rather than neurogenesis, and evaluating the full anxiolytic benefit requires weeks.

Can lion's mane cause anxiety?

No randomized controlled trial has documented anxiety as an adverse effect of lion's mane, and the Menon 2025 systematic review found no serious adverse effects across the evidence base. Some users anecdotally report initial anxiety when starting, which may relate to acute NGF/BDNF stimulation effects in sensitive individuals before the neurogenesis pathway produces calming effects. If this occurs, reducing the dose and titrating up slowly is the most common approach, though this is not based on clinical trial guidance.

What is the best dose of lion's mane for anxiety?

The clinical trials used doses ranging from 500mg to 5g daily, with formulation differences making direct comparison difficult. Standardized extract doses of 500mg to 2g daily cover the range most commonly studied. The Menon 2025 systematic review found doses of 500mg to 3g daily to be consistently well-tolerated. The most important variable is not the exact dose but consistency: lion's mane's neurogenesis-dependent anxiolytic mechanism requires weeks of daily use to develop.

Does lion's mane raise NGF?

Yes. Kim et al. (2008) demonstrated NGF-inducing activity in human astrocyte cells. Erinacines from the mycelium stimulate NGF synthesis by glial cells in the brain; hericenones from the fruiting body activate ERK1/2 signaling that promotes neurotrophic factor production including NGF. Vigna et al. (2019) documented rising BDNF (a related neurotrophic factor) in humans taking lion's mane alongside mood improvements, providing indirect human biomarker evidence for the neurotrophic mechanism.

Is lion's mane or reishi better for anxiety?

They work through different mechanisms and likely help different anxiety profiles. Lion's mane acts via hippocampal neurogenesis (NGF/BDNF pathway): it rebuilds the brain's capacity to regulate stress and emotion, an effect that takes weeks. Reishi modulates the GABAergic system and HPA axis, reducing cortisol and calming hyperarousal more acutely. People whose anxiety is driven by chronic stress and hippocampal atrophy may respond better to lion's mane; people with hyperarousal and elevated cortisol may respond better to reishi. No head-to-head trial has compared them.

Sources & References

1. 1RTHM-00194·Nagano, Mayumi et al. (2010). “Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake..” Biomedical research (Tokyo.Study breakdown →PubMed →↩
2. 2RTHM-00590·Vigna, Luisella et al. (2019). “Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?.” Evidence-based complementary and alternative medicine : eCAM.Study breakdown →PubMed →↩
3. 3RTHM-00973·Li, I-Chen et al. (2018). “Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines..” Behavioural neurology.Study breakdown →PubMed →↩
4. 4RTHM-01044·Chong, Pit Shan et al. (2019). “Therapeutic Potential of Hericium erinaceus for Depressive Disorder..” International journal of molecular sciences.Study breakdown →PubMed →↩
5. 5RTHM-01610·Rodriguez, Mya N et al. (2022). “Lion's Mane (Hericium erinaceus) Exerts Anxiolytic Effects in the rTg4510 Tau Mouse Model..” Behavioral sciences (Basel.Study breakdown →PubMed →↩
6. 6RTHM-01003·Ryu, Sun et al. (2018). “Hericium erinaceus Extract Reduces Anxiety and Depressive Behaviors by Promoting Hippocampal Neurogenesis in the Adult Mouse Brain..” Journal of medicinal food.Study breakdown →PubMed →↩
7. 7RTHM-01338·Chong, Pit Shan et al. (2021). “Neurogenesis-dependent antidepressant-like activity of Hericium erinaceus in an animal model of depression..” Chinese medicine.Study breakdown →PubMed →↩
8. 8RTHM-01746·Martínez-Mármol, Ramón et al. (2023). “Hericerin derivatives activates a pan-neurotrophic pathway in central hippocampal neurons converging to ERK1/2 signaling enhancing spatial memory..” Journal of neurochemistry.Study breakdown →PubMed →↩
9. 9. Source details for this reference are not yet available.
10. 10RTHM-00952·Surendran, Geyan et al. (2025). “Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study..” Frontiers in nutrition.Study breakdown →PubMed →↩
11. 11RTHM-00943·Menon, Arya et al. (2025). “Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review..” Frontiers in nutrition.Study breakdown →PubMed →↩
12. 12RTHM-00837·Lazur, Jan et al. (2023). “Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review..” Antioxidants (Basel.Study breakdown →PubMed →↩